000 | 01988 a2200565 4500 | ||
---|---|---|---|
005 | 20250517184202.0 | ||
264 | 0 | _c20180904 | |
008 | 201809s 0 0 eng d | ||
022 | _a1470-8728 | ||
024 | 7 |
_a10.1042/BCJ20170803 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFan, Ying | |
245 | 0 | 0 |
_aInterrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. _h[electronic resource] |
260 |
_bThe Biochemical journal _c01 2018 |
||
300 |
_a23-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
650 | 0 | 4 |
_aAntibodies, Phospho-Specific _xchemistry |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aEnzyme Assays |
650 | 0 | 4 |
_aEpitopes _xchemistry |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 |
_aGyrus Cinguli _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNeutrophils _ximmunology |
650 | 0 | 4 |
_aParkinson Disease _xenzymology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_arab GTP-Binding Proteins _xchemistry |
700 | 1 | _aHowden, Andrew J M | |
700 | 1 | _aSarhan, Adil R | |
700 | 1 | _aLis, Pawel | |
700 | 1 | _aIto, Genta | |
700 | 1 | _aMartinez, Terina N | |
700 | 1 | _aBrockmann, Kathrin | |
700 | 1 | _aGasser, Thomas | |
700 | 1 | _aAlessi, Dario R | |
700 | 1 | _aSammler, Esther M | |
773 | 0 |
_tThe Biochemical journal _gvol. 475 _gno. 1 _gp. 23-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1042/BCJ20170803 _zAvailable from publisher's website |
999 |
_c27777879 _d27777879 |